🔗 Share this article

Given that the United States proceeds with sweeping revisions to its vaccine guidelines, a particular individual has surfaced somewhat surprisingly: Høeg, a Danish American physician and public health researcher who first made her name by questioning COVID-19 vaccinations throughout the pandemic and has concentrated on alleged fatalities following Covid vaccination in her short tenure at the Food and Drug Administration.

Scheduled Shifts to Childhood Immunization Schedule

Health officials had intended to unveil sweeping revisions to the pediatric immunization program recently, synchronizing the US with Denmark’s immunization schedule, sources say – a significant shift that would put the US out of step with much of the world with insufficient data for improved outcomes. The announcement has been postponed until the next year.

Rather than the top vaccines chief, Tracy Beth Høeg is scheduled to speak at the meeting. She was just designated interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to run the division this year.

Consolidating Power at the FDA

Høeg's temporary position may indicate a strengthened alliance between the pharmaceutical and vaccine centers as Dr. Høeg and Dr. Prasad solidify control at the agency – and it points to a renewed priority upon dismantling long-standing immunizations at the FDA.

Dr. Høeg has often pushed for ending specific childhood immunization guidelines in the US in order to be more similar to Denmark, a nation with comprehensive healthcare and a number of inhabitants about the size of Wisconsin’s.

So far statements, she has continued to focus on immunizations – typically the responsibility of Dr. Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to drug regulation.

Doubts Over Qualifications

Høeg has no obvious experience in medication creation, oversight or management, which has been typical for former directors of the CBER. She has served at the FDA as a top consultant to the FDA chief and CBER since spring.

“She doesn’t seem to have the necessary background” for running the drug-regulation department, remarked Dr. Jonathan Howard. “She has not conducted a randomized controlled trial. She is not versed in managing a major agency. She is not an expert in industry regulation.”

Past commissioners of the center would “be deeply familiar with laws and regulations and the research of drug development”, noted a former acting FDA commissioner. “Clearly, she has not acquired the sort of resume that former directors who headed CBER have had.”

CDER has an vast workload at the FDA, she pointed out.

“Everybody just pays attention on the innovative therapies, but the off-patent medication office approves a multitude of off-brand pharmaceuticals. There is also a biologic copycat branch, OTC medication office and other areas, and every single one must be looked after,” she noted. “The responsibility you don’t keep your eye on, that is precisely what that I always told people is going to come back to haunt you.”

There is also, a significant management aspect to the job, which manages over 5,000 staff members. “It’s a enormous management job, if you perform it correctly,” she added.

Agency Reaction and Disputed Initiatives

Regarding inquiries about Høeg’s qualifications and whether this assignment indicates increased cooperation among agency officials on vaccines, a spokesperson responded that the “inquiries are based on flawed premises”.

“Her resume is consistent with the responsibilities of her job,” the representative explained, noting the months Dr. Høeg spent guiding the FDA commissioner on “pharmaceutical safety and regulatory science, including predictive safety algorithms and shot safety tracking”.

As acting director, Dr. Høeg takes over the agency head's new priority voucher program, a disputed one-day drug-approval program that apparently concerned her former heads. “By what process are these therapies being selected for this fast-track system? Who is making the calls?” Howard asked. “There is a lot of secrecy going on at the agency right now.”

Overall, he stated, “the agency seems to be moving towards more relaxed rules of all drugs, with the exception of shots.”

Public Past Work on Vaccines

With immunizations, Høeg has a more documented, if problematic, past, Howard said. She authored a analysis using non-validated crowd-sourced reports to assess the rate of heart inflammation after COVID-19 immunization. She advised the state of Florida top health official Joseph Ladapo, who reportedly have changed statistics to imply Covid vaccinations are riskier than they are.

Included in her “wish list” for the current government featured altering guidelines for new vaccines and ending “optional” vaccines, she remarked after the election on a audio program. At the agency, Dr. Høeg has reportedly proposed excluding adolescent males from obtaining COVID-19 vaccines.

“She is an thorough dogmatist who begins with her conclusions and works backwards to accommodate the evidence in a very misleading, dishonest fashion,” Howard said.

Taking Control and a “Campaign of Retribution”

Høeg aligned with fellow dissenters, {like|